Faslodex intramuscular injection 250mg, manufactured by AstraZeneca, contains Fulvestrant. With YJ code 4291421G1020 and standard 250mg 5mL tube, it is an estrogen receptor antagonist used to treat hormone receptor-positive metastatic breast cancer.
Faslodex intramuscular injection 250mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).